Human Techpole, Alisei and CL.A.N. together for the promotion of Life Sciences and Agrifood sectors
30 Oct – The Human Technopole Foundation signed an MoU with the National Technology Cluster Advanced Life Science in Italy (ALISEI) and the National Technology Agrifood Cluster (CL.A.N.). The objectives of the MoU are the promotion and the development of the life-sciences and agri-food sectors at an international and national levels.
The MoU aims to foster the collaboration between business, national and private bodies involved in the life-sciences and agri-food sectors. This will lead to the creation of an eco-system able to further strengthen the Italian role in these sectors at a European and international level.
According to Marco Simoni, president of the Human Technopole Foundation “this MoU is an example of how we intend Human Technopole’s mission – the promotion of a high-level scientific research, in collaboration with scientific, academic and industrial bodies for the benefit of Italian citizens. We strongly believe this will generate value in terms of knowledge and of investments for our Country”
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.